Platform
Features
0 followers
Urovant Sciences, innovations in urology. Our lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist
Industries
Headquarters
Employees
Links
James Robinson
33 members
10 members
5 members
8 members
Vaxcyte
2 followers
89bio
BioTeam
Watchmaker Genomics
1 follower
Cue Biopharma
eGenesis
Thermo Fisher Scientific
167 followers
Genentech
150 followers
Gilead Sciences
128 followers
Akari Therapeutics
Illumina
67 followers
Explore companies